Cargando…

Clinical and Molecular Data Define a Diagnosis of Arrhythmogenic Cardiomyopathy in a Carrier of a Brugada-Syndrome-Associated PKP2 Mutation

Plakophilin-2 (PKP2) is the most frequently mutated desmosomal gene in arrhythmogenic cardiomyopathy (ACM), a disease characterized by structural and electrical alterations predominantly affecting the right ventricular myocardium. Notably, ACM cases without overt structural alterations are frequentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Persampieri, Simone, Pilato, Chiara Assunta, Sommariva, Elena, Maione, Angela Serena, Stadiotti, Ilaria, Ranalletta, Antonio, Torchio, Margherita, Dello Russo, Antonio, Basso, Cristina, Pompilio, Giulio, Tondo, Claudio, Casella, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288341/ https://www.ncbi.nlm.nih.gov/pubmed/32443836 http://dx.doi.org/10.3390/genes11050571

Ejemplares similares

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
por: Pilato, Chiara Assunta, et al.
Publicado: (2018)

Fibrosis in Arrhythmogenic Cardiomyopathy: The Phantom Thread in the Fibro-Adipose Tissue
por: Maione, Angela Serena, et al.
Publicado: (2020)

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
por: Stadiotti, Ilaria, et al.
Publicado: (2017)

Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling
por: Rurali, Erica, et al.
Publicado: (2019)

Cardiac Biomarkers and Autoantibodies in Endurance Athletes: Potential Similarities with Arrhythmogenic Cardiomyopathy Pathogenic Mechanisms
por: Stadiotti, Ilaria, et al.
Publicado: (2021)

Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?
por: Moccia, Francesco, et al.
Publicado: (2019)

Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy
por: Maione, Angela Serena, et al.
Publicado: (2021)

Cell models of arrhythmogenic cardiomyopathy: advances and opportunities
por: Sommariva, Elena, et al.
Publicado: (2017)

Endomyocardial Biopsy: The Forgotten Piece in the Arrhythmogenic Cardiomyopathy Puzzle
por: Casella, Michela, et al.
Publicado: (2021)

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy
por: Sommariva, E., et al.
Publicado: (2016)

MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy
por: Sommariva, Elena, et al.
Publicado: (2017)

Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50
por: Ermon, Benedetta, et al.
Publicado: (2018)

Ca(2+) dysregulation in cardiac stromal cells sustains fibro-adipose remodeling in Arrhythmogenic Cardiomyopathy and can be modulated by flecainide
por: Maione, Angela S., et al.
Publicado: (2022)

Oxidized LDL‐dependent pathway as new pathogenic trigger in arrhythmogenic cardiomyopathy
por: Sommariva, Elena, et al.
Publicado: (2021)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2021)

Patient-specific primary and pluripotent stem cell-derived stromal cells recapitulate key aspects of arrhythmogenic cardiomyopathy
por: Maione, Angela Serena, et al.
Publicado: (2023)

Exploring digenic inheritance in arrhythmogenic cardiomyopathy
por: König, Eva, et al.
Publicado: (2017)

The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
por: Bos, Thomas A., et al.
Publicado: (2023)

Expression of Plakophilins (PKP1, PKP2, and PKP3) in Gastric Cancers
por: Demirag, Guzin G, et al.
Publicado: (2011)

Human Cell Modeling for Cardiovascular Diseases
por: Lippi, Melania, et al.
Publicado: (2020)

Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients
por: Lippi, Melania, et al.
Publicado: (2022)

Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients
por: Negro, Gabriele, et al.
Publicado: (2023)

Arrhythmogenic Right Ventricular Dysplasia and Brugada Syndrome Overlap
por: Rabah, Hussein, et al.
Publicado: (2021)

Stop-Gain Mutations in PKP2 Are Associated with a Later Age of Onset of Arrhythmogenic Right Ventricular Cardiomyopathy
por: Alcalde, Mireia, et al.
Publicado: (2014)

Novel frame-shift mutation in PKP2 associated with arrhythmogenic right ventricular cardiomyopathy: a case report
por: Trenkwalder, Teresa, et al.
Publicado: (2015)

PKP2 and DSG2 genetic variations in Latvian arrhythmogenic right ventricular dysplasia/cardiomyopathy registry patients
por: Bidina, Luize, et al.
Publicado: (2018)

Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy
por: Biernacka, Elżbieta K., et al.
Publicado: (2021)

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023)

An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Kataoka, Shohei, et al.
Publicado: (2016)

A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype
por: Al Sayed, Zeina R., et al.
Publicado: (2021)

Arrhythmogenic right ventricular cardiomyopathy mimicking Brugada – a case report
por: Al Jarallah, Mohammed, et al.
Publicado: (2023)

Efficacy of Catheter Ablation for Atrial Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy—A Multicenter Study
por: Gasperetti, Alessio, et al.
Publicado: (2021)

Endomyocardial biopsy in the hands of the electrophysiologist: the ‘one‐stop shop’ for arrhythmic non‐ischaemic cardiomyopathy. Letter regarding the article ‘Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy’
por: Compagnucci, Paolo, et al.
Publicado: (2021)

Diagnostic Dilemmas: Overlapping Features of Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy
por: Hoogendijk, Mark G.
Publicado: (2012)

The arrhythmogenic face of COVID-19: Brugada ECG pattern during acute infection
por: Lugenbiel, Patrick, et al.
Publicado: (2020)

Prevalence and characteristics of the Brugada electrocardiogram pattern in patients with arrhythmogenic right ventricular cardiomyopathy
por: Ueda, Nobuhiko, et al.
Publicado: (2021)

Phenotypic Variability of a Pathogenic PKP2 Mutation in an Italian Family Affected by Arrhythmogenic Cardiomyopathy and Juvenile Sudden Death: Considerations From Molecular Autopsy to Sport Restriction
por: Leone, Maria Pia, et al.
Publicado: (2021)

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2022)

Hybrid minithoracotomy approach for zero-fluoroscopy epicardial ablation of the arrhythmogenic substrate in Brugada syndrome
por: Cecchini, Federico, et al.
Publicado: (2022)

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6dflopdrm3h14qm2b21n60l5r